Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | COMP | PTBRY |
|---|---|---|
| Price | $9.29 | $9.89 |
| Change today | ▲ 0.76% | ▲ 4.60% |
| Market cap | $7.04B | $7.04B |
| Return, 3 months | -21.8% | +9.3% |
| Return, year to date | -12.1% | -16.7% |
| Return, 1 year | +21.6% | -11.4% |
| P/E (TTM) | 154.8 | 6.0 |
| P/B | 2.4 | 0.0 |
| P/E percentile vs own 5y | – | – |
| Dividend yield | – | 10.83% |
| Revenue growth (YoY, latest qtr) | – | – |
| Net profit growth (YoY) | – | – |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | – | – |
| Return on equity | – | – |
| Analyst target vs. price | – | – |
| Analyst buy share | – | – |
| RSI (14) | 38 | 32 |
| 30-day volatility | 42.7% | 48.4% |
| Max drawdown, 1 year | -50.8% | -39.0% |
| Trend read | Strong downtrend | Strong downtrend |
| Analyst consensus | – | – |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
